Contemporary OB/GYN week in review: Sildenafil cream, perinatal depression, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: Sildenafil cream, perinatal depression, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, June 24 - Friday, June 28, 2024), and click each link to read and watch anything you may have missed.
1.) Topical sildenafil cream shows efficacy for managing sexual arousal disorder
A recent study found that topical sildenafil cream improves sexual arousal outcomes in women with female sexual arousal disorder, offering a potential new treatment option.
Click here for the full article.
2.) Perinatal depression linked to increased midlife cardiovascular disease risk
A recent study revealed a 36% increased risk of cardiovascular disease among women with perinatal depression, highlighting the need for incorporating reproductive health assessment into cardiovascular health evaluations.
Click here for the full article.
3.) Study shows low pregnancy risk with same-day contraceptive initiation
A recent study found that starting contraceptives on the same day of consultation poses a low pregnancy risk, offering a viable option to reduce unintended pregnancies.
Click here for the full article.
4.) Fertility-sparing surgery matches standard surgery in cervical cancer survival
A recent study reveals that fertility-sparing surgery offers similar survival outcomes to standard surgery for cervical cancer patients with tumors of 4 cm or smaller, potentially expanding treatment options for younger women.
Click here for the full article.
5.) Impact of Dobbs v. Jackson on oral contraceptive prescriptions
A recent study revealed that the Supreme Court's Dobbs Dobbs decision is linked to reduced oral contraceptive prescriptions, highlighting the need for improved access amidst restrictive abortion policies.
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
